Aging. Aging, Biological . Biological Aging . Senescence . The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. . 1.00
Growth and Development. Development and Growth . The series of changes to the shape, size, components, and functions of an individual organism that occur over time as the organism progresses from its initial form to full size and maturity. . 0.43
Glycomics. Glycobiology . The systematic study of the structure and function of the complete set of glycans (the glycome) produced in a single organism and identification of all the genes that encode glycoproteins. . 0.39
Reverse Genetics. Genetics, Reverse . The use of techniques that produce a functional MUTATION or an effect on GENE EXPRESSION of a specific gene of interest in order to identify the role or activity of the gene product of that gene. . 0.36
Nasal Decongestants. Vasoconstrictors, Nasal . Agents, Nasal Vasoconstrictor . Decongestants, Nasal . Nasal Vasoconstrictor Agents . Nasal Vasoconstrictors . Decongestants . Vasoconstrictor Agents, Nasal . Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) . 0.35
Nuclear Pore Complex Proteins. Nucleoporin . Nucleoporins . Proteins that form the structure of the NUCLEAR PORE. They are involved in active, facilitated and passive transport of molecules in and out of the CELL NUCLEUS. . 0.35
Survival Analysis. Analysis, Survival . Analyses, Survival . Survival Analyses . Cox's Regression . A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. . 0.35